4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-17-053434
Options or other derivatives
- Chief Scientific Officer acquired 385,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Scientific Officer | 2017-08-22 | Grant or award · Stock Options | +385,000 | 1,110,000 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…